AGWCA
MLAB icon

Annis Gardner Whiting Capital Advisors’s Mesa Laboratories MLAB Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-94
Closed -$8.86K – 1344
2025
Q2 		$8.86K Buy
+94
New +$10.3K ﹤0.01% 747

Other funds holding MLAB

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
SCM
Simcoe Capital Management New York $549M AUM 24.95% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's MLAB Position: Q3 2025 in Review

Annis Gardner Whiting Capital Advisors sold out of Mesa Laboratories (MLAB) in Q3 2025, closing a stake of 94 shares — an estimated $8.86K sold.

Annis Gardner Whiting Capital Advisors first reported a position in MLAB in Q2 2025 and held it in 1 quarter. The position peaked at $8.86K in Q2 2025. 141 funds tracked by Wall St. Rank hold MLAB as of Q3 2025.

  • Annis Gardner Whiting Capital Advisors reported no remaining Mesa Laboratories position as of Q3 2025 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 94 Mesa Laboratories shares in Q3 2025, an estimated $8.86K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Mesa Laboratories in Q2 2025 and held it in 1 quarter.
  • Annis Gardner Whiting Capital Advisors's Mesa Laboratories position peaked at $8.86K in Q2 2025.
  • 141 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2025.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.